Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusei Miyazaki

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Journal of Neuroimmunology|June 7, 2021
Seasonal fluctuations in serum levels of vitamin D in Japanese patients with multiple sclerosisMasaaki Niino, Toshiyuki Fukazawa, Yusei Miyazaki, et al.
Multiple Sclerosis and Related Disorders|January 17, 2026
Characterizing spinal cord atrophy in multiple sclerosis patients without disease activity or brain atrophy progressionHiroaki Yokote, Yusei Miyazaki, Juichi Fujimori, et al.
Journal of Neuroimmunology|February 12, 2015
Decreased serum vitamin D levels in Japanese patients with multiple sclerosisMasaaki Niino, Shinya Sato, Toshiyuki Fukazawa, et al.
Immunological Medicine|November 8, 2022
Smoking and younger age at onset in anti-acetylcholine receptor antibody-positive myasthenia gravisYusei Miyazaki, Ken Sakushima, Masaaki Niino, et al.
Neurology and Therapy|July 16, 2024
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing SurveillanceTakashi Yamamura, Noriko Isobe, Izumi Kawachi, et al.
Clinical Immunology (Orlando, Fla.)|March 11, 2014
Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulationsYusei Miyazaki, Masaaki Niino, Toshiyuki Fukazawa, et al.
Neurology and Therapy|September 25, 2025
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing SurveillanceTakashi Yamamura, Noriko Isobe, Izumi Kawachi, et al.
Clinical Neurology and Neurosurgery|May 25, 2023
Processing speed test: Results from a Japanese normative sample of healthy participants compared with a US normative sampleMasaaki Niino, Yusei Miyazaki, Arman Altincatal, et al.
Internal Medicine (Tokyo, Japan)|August 28, 2024
Interleukin-6 Immunology in Macrophage Activation Syndrome Related to Neuroimmunological DiseasesTaichi Nomura, Masaaki Niino, Toshio Odani, et al.
Japanese Journal of Infectious Diseases|May 31, 2026
Clinical Characteristics and Neutralizing Antibody Levels in a Japanese Patient with Tick-borne Encephalitis: A Case ReportMegumi Uwatoko, Kazuma Tamiya, Ryoji Naganuma, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of Neuroimmunology|June 7, 2021
Seasonal fluctuations in serum levels of vitamin D in Japanese patients with multiple sclerosisMasaaki Niino, Toshiyuki Fukazawa, Yusei Miyazaki, et al.
Multiple Sclerosis and Related Disorders|January 17, 2026
Characterizing spinal cord atrophy in multiple sclerosis patients without disease activity or brain atrophy progressionHiroaki Yokote, Yusei Miyazaki, Juichi Fujimori, et al.
Journal of Neuroimmunology|February 12, 2015
Decreased serum vitamin D levels in Japanese patients with multiple sclerosisMasaaki Niino, Shinya Sato, Toshiyuki Fukazawa, et al.
Immunological Medicine|November 8, 2022
Smoking and younger age at onset in anti-acetylcholine receptor antibody-positive myasthenia gravisYusei Miyazaki, Ken Sakushima, Masaaki Niino, et al.
Neurology and Therapy|July 16, 2024
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing SurveillanceTakashi Yamamura, Noriko Isobe, Izumi Kawachi, et al.
Clinical Immunology (Orlando, Fla.)|March 11, 2014
Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulationsYusei Miyazaki, Masaaki Niino, Toshiyuki Fukazawa, et al.
Neurology and Therapy|September 25, 2025
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing SurveillanceTakashi Yamamura, Noriko Isobe, Izumi Kawachi, et al.
Clinical Neurology and Neurosurgery|May 25, 2023
Processing speed test: Results from a Japanese normative sample of healthy participants compared with a US normative sampleMasaaki Niino, Yusei Miyazaki, Arman Altincatal, et al.
Internal Medicine (Tokyo, Japan)|August 28, 2024
Interleukin-6 Immunology in Macrophage Activation Syndrome Related to Neuroimmunological DiseasesTaichi Nomura, Masaaki Niino, Toshio Odani, et al.
Japanese Journal of Infectious Diseases|May 31, 2026
Clinical Characteristics and Neutralizing Antibody Levels in a Japanese Patient with Tick-borne Encephalitis: A Case ReportMegumi Uwatoko, Kazuma Tamiya, Ryoji Naganuma, et al.
Pageof 6